Elucidating emergence and transmission of multidrug-resistant tuberculosis in treatment experienced patients by whole genome sequencing

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Clark, Taane G ^a   Mallard, Kim ^a   Coll, Francesc ^a   Preston, Mark ^a   Assefa, Samuel ^a,b   Harris, David ^b   Ogwang, Sam ^c   Mumbowa, Francis ^c,d   Kirenga, Bruce ^e   O'Sullivan, Denise M ^a   Okwera, Alphonse ^e   Eisenach, Kathleen D ^f,g   Joloba, Moses ^d   Bentley, Stephen D ^b   Ellner, Jerrold J ^h   Parkhill, Julian ^b   Jones López, Edward C ^h   McNerney, Ruth ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^c JOINT CLINICAL RESEARCH CENTRE   (Uganda)

^d MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

^e MULAGO HOSPITAL   (Uganda)

^f UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^g CASE WESTERN RESERVE UNIVERSITY   (United States)

^h BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID; CAPREOMYCIN; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; OFLOXACIN; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CLINICAL ARTICLE; DISEASE TRANSMISSION; FEMALE; GENE CLUSTER; GENE DELETION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HIGH THROUGHPUT SCREENING; HUMAN; LUNG TUBERCULOSIS; MALE; MIDDLE AGED; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; SINGLE NUCLEOTIDE POLYMORPHISM; UGANDA; YOUNG ADULT; BACTERIAL GENOME; CLINICAL TRIAL; DNA SEQUENCE; GENETICS; ISOLATION AND PURIFICATION; MULTICENTER STUDY; MUTATION; TRANSMISSION; TUBERCULOSIS, MULTIDRUG-RESISTANT;

ADULT; FEMALE; GENOME, BACTERIAL; HUMANS; MALE; MIDDLE AGED; MUTATION; MYCOBACTERIUM TUBERCULOSIS; POLYMORPHISM, GENETIC; SEQUENCE ANALYSIS, DNA; TUBERCULOSIS, MULTIDRUG-RESISTANT; UGANDA;

EID: 84892422034     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083012     Document Type: Article

References (60)

1. World Health Organisation (2012). Global Tuberculosis Report 2012 Geneva: WHO.
2. World Health Organisation (2010) The global plan to stop TB 2011-2015: transforming the fight towards elimination of tuberculosis. Geneva.
3. Dorman SE, Chaisson RE (2007) From magic bullets back to the Magic Mountain: the rise of extensively drug-resistant tuberculosis. Nat Med 13: 295-298. doi:10.1038/nm0307-295. PubMed: 17342143.
4. Zignol M, van Gemert W, Falzon D, Sismanidis C, Glaziou P et al. (2012) Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010. Bull World Health Organ 90: 111-119. doi:10.2471/BLT.11. 092585. PubMed: 22423162.
5. Jones-López EC, Ayakaka I, Levin J, Reilly N, Mumbowa F et al. (2011) Effectiveness of the standard WHO recommended retreatment regimen (category II) for tuberculosis in Kampala, Uganda: a prospective cohort study. PLoS Med 8: e1000427. PubMed: 21423586.
6. World Health Organisation (2011) Guidelines for the programmatic management of drug-resistant tuberculosis. 2011 Update. Geneva: WHO
7. Zhang Y, Yew WW (2009) Mechanisms of drug resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 13: 1320-1330. PubMed: 19861002.
8. Faustini A, Hall AJ, Perucci CA (2006) Risk factors for multidrug resistant tuberculosis in Europe: a systematic review. Thorax 61: 158-163. doi:10.1136/thx.2005.045963. PubMed: 16254056.
9. Ormerod LP (2005) Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment. Br Med Bull 73-74: 17-24. doi: 10.1093/bmb/ldh047. PubMed: 15956357.
10. Gandhi NR, Nunn P, Dheda K, Schaaf HS, Zignol M et al. (2010) Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet 375: 1830-1843. doi:10.1016/S0140- 6736(10)60410-2. PubMed: 20488523.
11. Sreevatsan S, Pan X, Stockbauer KE, Connell ND, Kreiswirth BN et al. (1997) Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination. Proc Natl Acad Sci U S A 94: 9869-9874. doi:10.1073/pnas.94.18.9869. PubMed: 9275218.
12. Walker TM, Ip CL, Harrell RH, Evans JT, Kapatai G et al. (2013) Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study. Lancet Infect Dis 13: 137-146. doi:10.1016/S1473-3099(12)70277-3. PubMed: 23158499.
13. Barnes PF, Cave MD (2003) Molecular epidemiology of tuberculosis. N Engl J Med 349: 1149-1156. doi:10.1056/NEJMra021964. PubMed: 13679530.
14. Niemann S, Köser CU, Gagneux S, Plinke C, Homolka S et al. (2009) Genomic diversity among drug sensitive and multidrug resistant isolates of Mycobacterium tuberculosis with identical DNA fingerprints. PLOS ONE 4: e7407. doi:10.1371/journal.pone.0007407. PubMed: 19823582.
15. Schürch AC, Kremer K, Daviena O, Kiers A, Boeree MJ et al. (2010) High-resolution typing by integration of genome sequencing data in a large tuberculosis cluster. J Clin Microbiol 48: 3403-3406. doi:10.1128/ JCM.00370-10. PubMed: 20592143.
16. Pérez-Lago L, Herranz M, Bouza E, García de Viedma D (2012) Dynamic and complex Mycobacterium tuberculosis microevolution unrevealed by standard genotyping. Tuberculosis (Edinb), 92: 232-5. PubMed: 22342248.
17. Filliol I, Motiwala AS, Cavatore M, Qi W, Hazbón MH et al. (2006) Global phylogeny of Mycobacterium tuberculosis based on single nucleotide polymorphism (SNP) analysis: insights into tuberculosis evolution, phylogenetic accuracy of other DNA fingerprinting systems, and recommendations for a minimal standard SNP set. J Bacteriol 188: 759-772. doi:10.1128/JB.188.2.759-772.2006. PubMed: 16385065.
18. Illuminana website. Available: Available online at: http://www.illumina. com/. Accessed 2013 November 10
19. Quail MA, Kozarewa I, Smith F, Scally A, Stephens PJ et al. (2008) A large genome center's improvements to the Illumina sequencing system. Nat Methods 5: 1005-1010. doi:10.1038/nmeth.1270. PubMed: 19034268.
20. Glenn TC (2011) Field guide to next-generation DNA sequencers. Mol Ecol Resour 11: 759-769. doi:10.1111/j.1755-0998.2011.03024.x. PubMed: 21592312.
21. Temple B, Ayakaka I, Ogwang S, Nabanjja H, Kayes S et al. (2008) Rate and amplification of drug resistance among previously-treated patients with tuberculosis in Kampala, Uganda. Clin Infect Dis 47: 1126-1134. doi:10.1086/592252. PubMed: 18808360.
22. Siddiqi SH (1995) BACTEC 460 TB System. Product and Procedure Manual. Sparks, MD: Becton Dickinson Diagnostic Instrument Systems
23. van Soolingen D, Hermans PW, de Haas PE, Soll DR, van Embden JD (1991) Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis. J Clin Microbiol 29: 2578-2586. PubMed: 1685494.
24. Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D et al. (1997) Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 35: 907-914. PubMed: 9157152.
25. Sola C, Filliol I, Gutierrez MC, Mokrousov I, Vincent V et al. (2001) Spoligotype database of Mycobacterium tuberculosis: biogeographic distribution of shared types and epidemiologic and phylogenetic perspectives. Emerg Infect Dis 7: 390-396. doi:10.3201/eid0703.010304. PubMed: 11384514.
26. Coll F, Mallard K, Preston MD, Bentley S, Parkhill J et al. (2012) SpolPred: rapid and accurate prediction of Mycobacterium tuberculosis spoligotypes from short genomic sequences. Bioinformatics 28: 2991-2993. doi:10.1093/bioinformatics/bts544. PubMed: 23014632.
27. Brudey K, Driscoll JR, Rigouts L, Prodinger WM, Gori A et al. (2006) Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiol 6: 23. doi: 10.1186/1471-2180-6-23. PubMed: 16519816.
28. Robinson T, Campino SG, Auburn S, Assefa SA, Polley SD et al. (2011) Drug-resistant genotypes and multi-clonality in Plasmodium falciparum analysed by direct genome sequencing from peripheral blood of malaria patients. PLOS ONE 6: e23204. doi:10.1371/journal.pone.0023204. PubMed: 21853089.
29. Wellcome Trust Sanger Institute website. Available: http://www.sanger.ac. uk/. Accessed 2013 November 10th
30. Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C et al. (1998) Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393: 537-544. doi:10.1038/31159. PubMed: 9634230.
31. Wellcome Trust Sanger Institute website. Avallable http://www.sanger. Available: ac.uk/resources/software/smalt/. Accessed 2013 November 10th
32. SAMtools website. Available: http://samtools.sourceforge.net/ Accessed 2013 November 10th
33. Chen K, Wallis JW, McLellan MD, Larson DE, Kalicki JM et al. (2009) BreakDancer: an algorithm for high-resolution mapping of genomic structural variation. Nat Methods 6: 677-681. doi:10.1038/nmeth.1363. PubMed: 19668202.
34. Wang J, Mullighan CG, Easton J, Roberts S, Heatley SL et al. (2011) CREST maps somatic structural variation in cancer genomes with base-pair resolution. Nat Methods 8: 652-654. doi:10.1038/nmeth.1628. PubMed: 21666668.
35. Ye K, Schulz MH, Long Q, Apweiler R, Ning Z (2009) Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads. Bioinformatics 25: 2865-2871. doi:10.1093/bioinformatics/btp394. PubMed: 19561018.
36. Rausch T, Zichner T, Schlattl A, Stütz AM, Benes V et al. (2012) DELLY: structural variant discovery by integrated paired-end and splitread analysis. Bioinformatics 28: i333-i339. doi:10.1093/bioinformatics/bts378. PubMed: 22962449.
37. Zerbino DR, Birney E (2008) Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Genome Res 18: 821-829. doi: 10.1101/gr.074492.107. PubMed: 18349386.
38. Weir BS (1996) Genetic data analysis II : Methods for discrete population genetic data. Sunderland MA USA: Sinauer Associates Inc.
39. Stamatakis A, Hoover P, Rougemont J (2008) A rapid bootstrap algorithm for the RAxML Web servers. Syst Biol 57: 758-771. doi: 10.1080/ 10635150802429642. PubMed: 18853362.
40. Gagneux S, DeRiemer K, Van T, Kato-Maeda M, de Jong BC et al. (2006) Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 103: 2869-2873. doi:10.1073/pnas.0511240103. PubMed: 16477032.
41. Demay C, Liens B, Burguière T, Hill V, Couvin D et al. (2012) SITVITWEB - a publicly available international multimarker database for studying Mycobacterium tuberculosis genetic diversity and molecular epidemiology. Infect Genet Evol 12: 755-766. doi:10.1016/j.meegid.2012.02.004. PubMed: 22365971.
42. Spearman C (1904) The proof and measurement of association between two things. American Journal of Psychology 15: 72-101. doi: 10.2307/1412159. PubMed: 21051364.
43. de Vos M, Müller B, Borrell S, Black PA, van Helden PD et al. (2013) Putative Compensatory Mutations in the rpoC Gene of Rifampin-Resistant Mycobacterium tuberculosis Are Associated with Ongoing Transmission. Antimicrob Agents Chemother 57: 827-832. doi:10.1128/AAC.01541-12. PubMed: 23208709.
44. Comas I, Borrell S, Roetzer A, Rose G, Malla B et al. (2012) Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes. Nat Genet 44: 106-110. PubMed: 22179134.
45. Brandis G, Hughes D (2013) Genetic characterization of compensatory evolution in strains carrying rpoB Ser531Leu, the rifampicin resistance mutation most frequently found in clinical isolates. J Antimicrob Chemother, 68: 2493-7. PubMed: 23759506.
46. DeBarber AE, Mdluli K, Bosman M, Bekker LG, Barry CE 3rd (2000) Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 97: 9677-9682. doi:10.1073/pnas.97.17. 9677. PubMed: 10944230.
47. Morlock GP, Metchock B, Sikes D, Crawford JT, Cooksey RC (2003) ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates. Antimicrob Agents Chemother 47: 3799-3805. doi:10.1128/AAC.47.12. 3799-3805.2003. PubMed: 14638486.
48. Cohen T, Sommers B, Murray M (2003) The effect of drug resistance on the fitness of Mycobacterium tuberculosis. Lancet Infect Dis 3: 13-21. doi:10.1016/S1473-3099(03)00483-3. PubMed: 12505028.
49. Pym AS, Saint-Joanis B, Cole ST (2002) Effect of katG mutations on the virulence of Mycobacterium tuberculosis and the implication for transmission in humans. Infect Immun 70: 4955-4960. doi:10.1128/IAI.70.9.4955-4960.2002. PubMed: 12183541.
50. Ando H, Kondo Y, Suetake T, Toyota E, Kato S et al. (2010) Identification of katG mutations associated with high-level isoniazid resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 54: 1793-1799. doi:10.1128/AAC.01691-09. PubMed: 20211896.
51. Kato-Maeda M, Ho C, Passarelli B, Banaei N, Grinsdale J et al. (2013) Use of Whole Genome Sequencing to Determine the Microevolution of Mycobacterium tuberculosis during an Outbreak. PLOS ONE 8: e58235. doi:10.1371/journal.pone. 0058235. PubMed: 23472164.
52. Bryant JM, Schürch AC, van Deutekom H, Harris SR, de Beer JL et al. (2013) Inferring patient to patient transmission of Mycobacterium tuberculosis from whole genome sequencing data. BMC Infect Dis 13: 110. doi:10.1186/1471- 2334-13-110. PubMed: 23446317.
53. Mallard K, McNerney R, Crampin AC, Houben R, Ndlovu R et al. (2010) Molecular detection of mixed infections of Mycobacterium tuberculosis strains in sputum samples from patients in Karonga District, Malawi. J Clin Microbiol 48: 4512-4518. doi:10.1128/JCM.01683-10. PubMed: 20962138.
54. Albert H, Trollip AP, Mole RJ, Hatch SJ, Blumberg L (2002) Rapid indication of multidrug-resistant tuberculosis from liquid cultures using FASTPlaqueTB-RIF, a manual phage-based test. Int J Tuberc Lung Dis 6: 523-528. PubMed: 12068986.
55. Traore H, Ogwang S, Mallard K, Joloba ML, Mumbowa F et al. (2007) Low-cost rapid detection of rifampicin resistant tuberculosis using bacteriophage in Kampala, Uganda. Ann Clin Microbiol Antimicrob 6: 1. doi:10.1186/1476-0711-6-1. PubMed: 17212825.
56. Van Deun A, Maug AK, Bola V, Lebeke R, Hossain MA et al. (2013) Rifampicin drug resistance tests for tuberculosis: challenging the gold standard. J Clin Microbiol.
57. Rigouts L, Gumusboga M, de Rijk WB, Nduwamahoro E, Uwizeye C et al. (2013) Rifampicin resistance missed in automated liquid culture system for mycobacterium tuberculosis with specific rpoB-mutations. J Clin Microbiol.
58. Zumla A, Abubakar I, Raviglione M, Hoelscher M, Ditiu L et al. (2012) Drug-resistant tuberculosis - current dilemmas, unanswered questions, challenges, and priority needs. J Infect Dis 205 Suppl 2: S228-S240. doi:10.1093/infdis/jir858. PubMed: 22476720.
59. Sreevatsan S, Pan X, Zhang Y, Kreiswirth BN, Musser JM (1997) Mutations associated with pyrazinamide resistance in pncA of Mycobacterium tuberculosis complex organisms. Antimicrob Agents Chemother 41: 636-640. PubMed: 9056006.
60. Wong SY, Lee JS, Kwak HK, Via LE, Boshoff HIM et al. (2011) Mutations in gidB Confer Low-Level Streptomycin Resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 55: 2515-2522. doi:10.1128/AAC.01814-10. PubMed: 21444711.